Condition

Gut Hormones

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 6 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials6
Recruiting0
Common interventions9
Lead sponsors shown4
Advertisement

Clinical trials

6 shown
Breaking Sitting and Metabolic Health in Sedentary Overweight and Obese AdultsNCT05306678 · 2020-12-29
COMPLETED
Effect of Meal Texture on Glucose-metabolism and Gut Hormone Response After Bariatric SurgeryNCT04082923 · 2019-10-03
COMPLETED
Fat Metabolites and Gut HormonesNCT03223389 · 2017-08-07
UNKNOWN
Mechanisms of Inflammation, Immunity, Islet Cell and Intestinal Hormone Changes in Youth at Risk for DiabetesNCT04031222 · 2017-05-19
COMPLETED
The Effect of Breakfast With Different Macronutrient Composition on PYY, Ghrelin, GLP-1,Glucose Level, VAS for Hunger, VAS for Satiety and Ad Libitum Intake 4 Hours After Breakfast in Obese WomenNCT03697486 · 2010-10-01
COMPLETED
The Comparison of PYY, Ghrelin, GLP1, Glucose Level, Level of Satiety, and Ad Libitum Intake in Obese and Non-Obese Patients After Breakfast With Balanced Macronutrient CompositionNCT03701503 · 2010-10-01
COMPLETED

Trial status mix

COMPLETED5
UNKNOWN1

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.